en English

Encouraging Early Results for Prostate Cancer Screening

Early Encouraging Results Investigational Use 99mTc-iPSMA

Dosing of First Patients Shows Encouraging Early Results in the Investigational Use of 99mTc-iPSMA for Prostate Cancer Screening

Article by Doctor Omar Yehia, PI at the Misr Radiology Center Cairo, Egypt

As part of the NOBLE (NOBody LEft behind) Registry that aims to generate data repository – which may inform further development of PSMA-SPECT products for adequate diagnostic imaging of prostate cancer, the first experience from one of the centers involved is promising.

Doctor Omar Yehia is the Principal Investigator enrolled in the NOBLE Registry at the MISR Radiology Center in Cairo, Egypt. Early experience indicates that 99mTc-iPSMA SPECT can potentially identify lesions and important disease characteristics using technology which is already available in emerging markets. Read full article from Radiotheranostics Today from Oncidium foundation.

Share this post !

Share on facebook
Share on linkedin
Share on twitter
Share on email

The information on this Website is provided for information purposes only and made available on the understanding that it does not constitute professional or expert medical advice. If you are a patient using this Website, you should seek assistance from a health care professional when interpreting these materials and applying them to your individual circumstances.

If you have any concerns about your health, consult your general practitioner. Information provided on this Website does not imply endorsement of third-party services or products and cannot provide you with health and medical advice.

Use of site is subject to the terms of use and privacy policy.

Do you agree to continue ?

If you choose not to accept the terms and conditions of use, the website page will close instantly.